Terms: = Lymphoma AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
745 results:
1. Advancements in cancer immunotherapies targeting cd20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells.
Dabkowska A; Domka K; Firczuk M
Front Immunol; 2024; 15():1363102. PubMed ID: 38638442
[TBL] [Abstract] [Full Text] [Related]
2. Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma.
Nylund P; Nikkarinen A; Ek S; Glimelius I
Front Immunol; 2024; 15():1373269. PubMed ID: 38566987
[TBL] [Abstract] [Full Text] [Related]
3. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract] [Full Text] [Related]
4. [Studies on clinicopathological features of duodenal-type follicular lymphoma of 18 patients].
Du YR; Li J; Li SX; Guan CY; Li HL; Gao ZF; Li X; Dong GH
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):94-97. PubMed ID: 38527846
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides.
Porkert S; Griss J; Hudelist-Venz M; Steiner I; Valencak J; Weninger W; Brunner PM; Jonak C
J Dtsch Dermatol Ges; 2024 Apr; 22(4):532-550. PubMed ID: 38444271
[TBL] [Abstract] [Full Text] [Related]
6. An evaluation of glofitamab, the first fixed-duration bispecific antibody for relapsed or refractory large B-cell lymphomas.
Polgarova K; Trneny M
Expert Opin Biol Ther; 2024; 24(1-2):7-13. PubMed ID: 38305755
[TBL] [Abstract] [Full Text] [Related]
7. Tumoural Pellino-1 expression and Pellino-1-expressive cytotoxic T-cells are associated with poor prognosis in diffuse large B-cell lymphoma.
Shin SJ; Ko J; Hwang HS; Huh J; Lee CW; Lee JK; Go H
Pathology; 2024 Apr; 56(3):374-381. PubMed ID: 38296676
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
10. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
[TBL] [Abstract] [Full Text] [Related]
11. [Pharmacological characteristics and clinical outcomes of Epcoritamab (recombinant) (Epkinly
Takaura K; Ando H; Ganoza ER
Nihon Yakurigaku Zasshi; 2024; 159(1):61-68. PubMed ID: 38171842
[TBL] [Abstract] [Full Text] [Related]
12. [miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9].
Li B; Tao Q; Hu X; Li T; Bao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1074-1082. PubMed ID: 38140866
[TBL] [Abstract] [Full Text] [Related]
13. Primary central nervous system marginal zone lymphoma.
Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
[TBL] [Abstract] [Full Text] [Related]
14. [Analysis of 9 cases of pediatric-type follicular lymphoma].
Li GP; Zhang D; Wang YQ; Li ZY; Yuan FF; Li MH; Wang L; Du JW; Zhang LN; Li YF; Wei XD; Fu YW
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1129-1132. PubMed ID: 38018051
[No Abstract] [Full Text] [Related]
15. Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphoma.
Matarasso S; Assouline S
Future Oncol; 2023 Oct; 19(31):2083-2101. PubMed ID: 37882361
[TBL] [Abstract] [Full Text] [Related]
16. Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Bodet-Milin C; Morvant C; Carlier T; Frecon G; Tournilhac O; Safar V; Kraeber-Bodere F; Le Gouill S; Macintyre E; Bailly C
Sci Rep; 2023 Oct; 13(1):18177. PubMed ID: 37875524
[TBL] [Abstract] [Full Text] [Related]
17. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
[TBL] [Abstract] [Full Text] [Related]
18. Ensitrelvir eradicates persistent SARS-CoV-2 infection in a follicular lymphoma patient treated with anti-cd20 antibodies.
Sakamaki I; Negoro E; Iwasaki H; Yamauchi T
J Infect Chemother; 2024 Feb; 30(2):147-149. PubMed ID: 37690521
[TBL] [Abstract] [Full Text] [Related]
19. Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma.
Dittrich K; Yıldız-Altay Ü; Qutab F; Kwong DA; Rao Z; Nievez-Lozano SA; Gardner HL; Richmond JM; London CA
PLoS One; 2023; 18(8):e0290428. PubMed ID: 37624862
[TBL] [Abstract] [Full Text] [Related]
20. lymphomas of Central Nervous System.
Yokogami K; Azuma M; Takeshima H; Hirai T
Adv Exp Med Biol; 2023; 1405():527-543. PubMed ID: 37452952
[TBL] [Abstract] [Full Text] [Related]
[Next]